chartexchange

LGNYZ
LIGAND PHARMS GENERAL CVR
stockOTCRight

EODOct 2, 2026
0.05USD-16.667%(-0.01)50,000
Loading…
Loading…
900,000
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
San Diego, CA, USA
Previous Close
$0.06
Beta
3.24
52-Week High
$0.09 2026-04-24
52-Week Low
$0.03 2026-07-02
SMA 50
$0.05
SMA 200
$0.04
Avg. Vol 10D
517,606
Avg. Vol 30D
558,542
Avg. Vol 90D
352,900
Relative Vol
0.09
19.55M
11,355
LGNYZ Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGNYZ Performance
PeriodPriceDateChangeBeta
1W0.062026-10-01-16.67%0.000
1M0.052026-08-28-2.72%-59.511
3M0.052026-07-06+11.11%-4.475
6M0.052026-04-01-5.66%6.765
1Y0.062025-10-01-9.09%3.244
2Y0.012024-10-01+566.67%—
5Y0.012021-10-08+395.05%-0.157
LGNYZ Stock Summary

LIGAND PHARMS GENERAL CVR (OTC:LGNYZ) stock price today is $0.05, and today's volume is 50,000. LGNYZ is down 16.667% today. The 30 day average volume is 558,542. LGNYZ market cap is $900,000 with 18.00M shares outstanding.